What is this medicine?
IDARUBICIN (eye da RUE bi sin) is a chemotherapy drug. This medicine is used to treat acute myeloid leukemia (AML).
How should I use this medicine?
This drug is given as an infusion into a vein. It is administered in a hospital or clinic by a specially trained health care professional. If you have pain, swelling, burning or any unusual feeling around the site of your injection, tell your health care professional right away.
Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
low blood counts - this medicine may decrease the number of white blood cells, red blood cells and platelets. You may be at increased risk for infections and bleeding.
signs of infection - fever or chills, cough, sore throat, pain or difficulty passing urine
signs of decreased platelets or bleeding - bruising, pinpoint red spots on the skin, black, tarry stools, blood in the urine
signs of decreased red blood cells - unusually weak or tired, fainting spells, lightheadedness
fast, irregular heartbeat
pain, swelling, redness at site where injected
swelling of ankles, feet, or hands
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
red colored urine
What may interact with this medicine?
medicines to increase blood counts like filgrastim, pegfilgrastim, sargramostim
Talk to your doctor or health care professional before taking any of these medicines:
What if I miss a dose?
It is important not to miss your dose. Call your doctor or health care professional if you are unable to keep an appointment.
Where should I keep my medicine?
This drug is given in a hospital or clinic and will not be stored at home.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
infection (especially a virus infection such as chickenpox, cold sores, or herpes)
recent or ongoing radiation therapy
an unusual or allergic reaction to idarubicin, other chemotherapy agents, other medicines, foods, dyes, or preservatives
pregnant or trying to get pregnant
What should I watch for while using this medicine?
Your condition will be monitored carefully while you are receiving this medicine. You will need important blood work done while you are taking this medicine.
This drug may make you feel generally unwell. This is not uncommon, as chemotherapy can affect healthy cells as well as cancer cells. Report any side effects. Continue your course of treatment even though you feel ill unless your doctor tells you to stop.
Your urine may turn orange-red for a few days after your dose. This is not blood. If your urine is dark or brown, call your doctor.
In some cases, you may be given additional medicines to help with side effects. Follow all directions for their use.
Call your doctor or health care professional for advice if you get a fever, chills or sore throat, or other symptoms of a cold or flu. Do not treat yourself. This drug decreases your body's ability to fight infections. Try to avoid being around people who are sick.
This medicine may increase your risk to bruise or bleed. Call your doctor or health care professional if you notice any unusual bleeding.
Be careful brushing and flossing your teeth or using a toothpick because you may get an infection or bleed more easily. If you have any dental work done, tell your dentist you are receiving this medicine.
Avoid taking products that contain aspirin, acetaminophen, ibuprofen, naproxen, or ketoprofen unless instructed by your doctor. These medicines may hide a fever.
Do not become pregnant while taking this medicine. Women should inform their doctor if they wish to become pregnant or think they might be pregnant. There is a potential for serious side effects to an unborn child. Talk to your health care professional or pharmacist for more information. Do not breast-feed an infant while taking this medicine.
Men may have a lower sperm count while taking this medicine. Talk to your doctor if you plan to father a child.
There is a maximum amount of this medicine you should receive throughout your life. The amount depends on the medical condition being treated and your overall health. Your doctor will watch how much of this medicine you receive in your lifetime. Tell your doctor if you have taken this medicine before.
Online Medical Reviewer:
Date Last Reviewed: Unavailable
NOTE:This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider. Copyright© 2019 Elsevier
- Arsenic Trioxide injection
- Asparaginase (E. coli) Solution for injection
- Azacitidine suspension for injection (subcutaneous use)
- Busulfan injection
- Busulfan tablets
- Cladribine injection for infusion
- Cyclophosphamide injection
- Cyclophosphamide tablets or Capsules
- Cytarabine, ARA-C injection
- Daunorubicin injection
- Doxorubicin injection
- Filgrastim, G-CSF injection
- Gemtuzumab Ozogamicin (Human)(Murine) Solution for injection
- Hydroxyurea capsules
- Imatinib tablets
- Interferon Alfa-2a injection
- Lenalidomide Oral Capsules
- Mechlorethamine, Nitrogen Mustard injection
- Mechlorethamine topical gel
- Mercaptopurine, 6-MP oral suspension
- Mercaptopurine, 6-MP tablets
- Methotrexate injection
- Methotrexate subcutaneous injection
- Methotrexate tablets
- Mitoxantrone injection
- Pegaspargase injection
- Sargramostim, GM-CSF injection
- Teniposide injection
- Thioguanine, 6-TG tablets
- Vincristine injection